Archive for the ‘Commentary’ Category

Making a case for research investment in Canada: Can we drive reverse brain drain now?

Author: Camila Londono, 01/11/17

Brain drain was a real problem for Canada in the late ‘90s. A study by Statistics Canada found that twice as many post-secondary professors and teachers went to the United States than came to Canada in that period. This untenable situation—in which education and infrastructure investments in people were lost through decreased funding, higher taxes…Read more

Inaugural Medicine by Design Symposium – Engineering progress in regenerative medicine

Author: Nicole Forgione, 12/21/16

On November 28 local and international leaders of the regenerative medicine (RM) community gathered at the MaRS Centre in Toronto for the first ever Medicine by Design (MbD) Symposium. The event marked the first year of the MbD program at the University of Toronto (U of T). This initiative was established based on a $114…Read more

Right Turn: Every damn swan – a note on the scientific hypothesis

Author: Guest, 12/02/16

Malgosia Pakulska is a research associate in the Shoichet lab at the University of Toronto and a science writer for Research2Reality, a blog designed to engage the public in Canadian research. Malgosia wants to educate, entertain, and show people what science is really like, one story at a time. When she is not in the lab,…Read more

Insights from CGTW16 – Part 3: Clinical trials, health economics and regulatory affairs

Author: Guest, 12/01/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Insights from CGTW16 – Part 2: scale-up challenges and closed systems

Author: Guest, 11/23/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Right Turn: What do the results of the U.S. election mean for science?

Author: Stacey Johnson, 11/09/16

This isn’t the blog that I planned to write this week, but I’m so preoccupied with the outcome of the U.S. election, I’m finding it hard to focus on anything else right now. So, let’s look at the implications of a Trump presidency on science. An article in Nature quotes Michael Lubell, director of public…Read more

Right Turn: The story of scurvy is a poignant cautionary tale for modern medical science

Author: Guest, 11/04/16

Elizabeth (Liz) Csaszar is a development manager for the BridGE team at CCRM. Her areas of interest are cell manufacturing, clinical translation of cell based therapies, and blood cell technologies. Liz obtained her PhD at the University of Toronto, focusing on the strategies to expand and self-renew hematopoietic stem cells in vitro. Liz is interested in…Read more

Lobbying for deregulation of stem cell procedures is giving rise to a new “dark economy”

Author: Hamideh Emrani, 10/31/16

Day 3 of the Till & McCulloch Meetings continued with many interesting talks. The one that I have chosen to write about in more detail Dr. Douglas Sipp’s, titled “The Stem Cell Dark Economy.” I think his talk was really thought provoking, and important to be shared with our readers. He began with an old…Read more

Challenging assumptions to expand our thinking? Insights from Session 1 of TMM2016

Author: Camila Londono, 10/25/16

The fifth Till & McCulloch Meetings started off with a bang, with an incredibly exciting and provocative talk by Dr. Sara-Jane Dunn that highlighted the predictive power of Boolean network models. Dr. Dunn, who works at Microsoft Research, introduced the idea of biological computation: a cell’s gene expression “decision making” can be modelled using Boolean…Read more

STEMinism: Chasing diversity and equality in STEM

Author: Camila Londono, 10/14/16

On October 11 I attended SHE DID THAT, the Ada Lovelace event, held at the University of Toronto, that Samantha Payne wrote about in Signals earlier this week. It was an exciting evening that not only celebrated incredible women in science, but also served as a reminder that we have a long way to go…Read more